Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan plus high-dose amoxicillin dual therapy versus vonoprazan-based triple therapy for Helicobacter pylori eradication
ChiCTR2000040955Phase 4Recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan, amoxicillin and clarithromycin in Helicobacter pylori infection (3 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoints: 13C urea breath test and 14C urea breath test. Started Dec 2020; status: recruiting.
02
Drugs
vonoprazanamoxicillinclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2000040955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040955.